AI scans tissue slides to predict which liver cancer treatments will work
NCT ID NCT07417800
Summary
This study is developing an artificial intelligence (AI) tool to help doctors choose the best treatment for patients after liver cancer surgery. The AI analyzes standard digital images of a patient's tumor tissue to predict whether they are likely to benefit from specific follow-up therapies, like chemoembolization or targeted drugs. The goal is to personalize treatment, avoid unnecessary side effects, and improve survival by matching the right patient with the right therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.